Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Cecil

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Surgical Oncology Clinics of North America|October 22, 2003
The etiology, clinical presentation, and management of pseudomyxoma peritoneiBrendan J Moran, Thomas D Cecil
Diseases of the Colon and Rectum|May 28, 2004
Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancerThomas D Cecil, Rosemary Sexton, Brendan J Moran, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 25, 2017
The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal originKaran Rangarajan, Kandiah Chandrakumaran, Sanjeev Dayal, et al.
Diseases of the Colon and Rectum|November 9, 2013
Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achievedSanjeev Dayal, Panagiotis Taflampas, Stefan Riss, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2018
Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritoneiKim Govaerts, K Chandrakumaran, Norman J Carr, et al.
The American Journal of Surgical Pathology|October 19, 2016
In ReplyNorman J Carr, Thomas D Cecil, Santiago González-Moreno, et al.
The American Journal of Surgical Pathology|October 23, 2015
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi ProcessNorman J Carr, Thomas D Cecil, Faheez Mohamed, et al.
Diseases of the Colon and Rectum|June 10, 2025
International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and AustraliaDaniel Steffens, Suzanne Alves, Cherry E Koh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Surgical Oncology Clinics of North America|October 22, 2003
The etiology, clinical presentation, and management of pseudomyxoma peritoneiBrendan J Moran, Thomas D Cecil
Diseases of the Colon and Rectum|May 28, 2004
Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancerThomas D Cecil, Rosemary Sexton, Brendan J Moran, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 25, 2017
The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal originKaran Rangarajan, Kandiah Chandrakumaran, Sanjeev Dayal, et al.
Diseases of the Colon and Rectum|November 9, 2013
Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achievedSanjeev Dayal, Panagiotis Taflampas, Stefan Riss, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2018
Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritoneiKim Govaerts, K Chandrakumaran, Norman J Carr, et al.
The American Journal of Surgical Pathology|October 19, 2016
In ReplyNorman J Carr, Thomas D Cecil, Santiago González-Moreno, et al.
The American Journal of Surgical Pathology|October 23, 2015
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi ProcessNorman J Carr, Thomas D Cecil, Faheez Mohamed, et al.
Diseases of the Colon and Rectum|June 10, 2025
International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and AustraliaDaniel Steffens, Suzanne Alves, Cherry E Koh, et al.
Pageof 1